| Literature DB >> 26622793 |
Yongwu Li1, Xiaonan Sun1, Q I Wang1, Qinxuan Zhou1, Benxing Gu1, Guozhi Shi1, Dongliang Jiang1.
Abstract
Intensity-modulated radiation therapy (IMRT) is able to achieve good target conformance with a limited dose to organs at risk (OARs); however, IMRT increases the irradiation volume and monitor units (MUs) required. The present study aimed to evaluate the use of an IMRT plan with fewer segments and MUs, while maintaining quality in the treatment of nasopharyngeal carcinoma. In the present study, two types of IMRT plan were therefore compared: The direct machine parameter optimization (DMPO)-RT method and the feedback constraint DMPO-RT (fc_DMPO-RT) method, which utilizes compensative feedback constraint in DMPO-RT and maintains optimization. Plans for 23 patients were developed with identical dose prescriptions. Each plan involved synchronous delivery to various targets, with identical OAR constraints, by means of 7 coplanar fields. The average dose, maximum dose, dose-volume histograms of targets and the OAR, MUs of the plan, the number of segments, delivery time and accuracy were subsequently compared. The fc_DMPO-RT exhibited superior dose distribution in terms of the average, maximum and minimum doses to the gross tumor volume compared with that of DMPO-RT (t=62.7, 20.5 and 22.0, respectively; P<0.05). The fc_DMPO-RT also resulted in a smaller maximum dose to the spinal cord (t=7.3; P<0.05), as well as fewer MUs, fewer segments and decreased treatment times than that of the DMPO-RT (t=6.2, 393.4 and 244.3, respectively; P<0.05). The fc_DMPO-RT maintained plan quality with fewer segments and MUs, and the treatment time was significantly reduced, thereby resulting in reduced radiation leakage and an enhanced curative effect. Therefore, introducing feedback constraint into DMPO may result in improved IMRT planning. In nasopharyngeal carcinoma specifically, feedback constraint resulted in the improved protection of OARs in proximity of targets (such as the brainstem and parotid) due to sharp dose distribution and reduced MUs.Entities:
Keywords: dose; feedback constraint optimization; nasopharyngeal carcinoma; radiation therapy
Year: 2015 PMID: 26622793 PMCID: PMC4579899 DOI: 10.3892/ol.2015.3523
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Patient characteristics (n=23) and planning target volumes in the present study.
| No. | Gender | Age, years | Pathology | Stage | PTV70, cm3 | mPTV60, cm3 | mPTV50, cm3 |
|---|---|---|---|---|---|---|---|
| 1 | M | 68 | Nk carcinoma | T4N1M0 | 196.2 | 552.8 | 244.0 |
| 2 | M | 65 | Udf carcinoma | T1N2M0 | 154.5 | 637.4 | 399.6 |
| 3 | F | 57 | Nk carcinoma | T2N2M0 | 123.1 | 355.0 | 426.7 |
| 4 | M | 56 | Pdf squamous carcinoma | T4N1M0 | 206.6 | 83.5 | 612.0 |
| 5 | M | 58 | Nk carcinoma | T4N2M0 | 192.5 | 290.7 | 689.7 |
| 6 | M | 64 | Nk carcinoma | T2N0M0 | 120.1 | 507.6 | 467.5 |
| 7 | M | 52 | Nk carcinoma | T2N2M0 | 216.0 | 342.1 | 117.3 |
| 8 | F | 61 | Udf carcinoma | T2N1M0 | 91.4 | 285.7 | 549.2 |
| 9 | M | 77 | Udf carcinoma | T2N2M0 | 119.5 | 128.6 | 538.3 |
| 10 | M | 49 | Udf carcinoma | T2N2M0 | 123.6 | 583.9 | 311.1 |
| 11 | M | 67 | Udf carcinoma | T2N1M0 | 248.1 | 467.2 | 830.3 |
| 12 | F | 56 | Nk carcinoma | T2N2M0 | 196.5 | 243.3 | 411.3 |
| 13 | M | 54 | Nk carcinoma | T3N0M0 | 149.8 | 492.1 | 295.3 |
| 14 | M | 64 | Nk carcinoma | T3N1M0 | 141.8 | 662.4 | 407.2 |
| 15 | M | 48 | Pdf squamous carcinoma | T4N1M0 | 135.5 | 438.4 | 363.4 |
| 16 | M | 59 | Nk carcinoma | T4N1M0 | 280.5 | 348.9 | 349.2 |
| 17 | M | 63 | Nk carcinoma | T4N1M0 | 140.7 | 621.3 | 346.1 |
| 18 | M | 36 | Pdf squamous carcinoma | T1N1M0 | 57.3 | 477.6 | 362.4 |
| 19 | F | 59 | Udf carcinoma | T2N0M0 | 62.6 | 290.0 | 263.9 |
| 20 | M | 52 | Udf carcinoma | T2N1M0 | 196.4 | 679.2 | 183.9 |
| 21 | M | 36 | Pdf squamous carcinoma | T2N3M0 | 173.1 | 478.9 | 886.9 |
| 22 | M | 46 | Udf carcinoma | T3N1M0 | 153.5 | 484.7 | 199.6 |
| 23 | M | 41 | Udf carcinoma | T3N2M0 | 382.8 | 269.2 | 423.6 |
M, male; F, female; Udf, undifferentiated; Nk, non-keratinized; Pdf, poorly differentiated; PTVn, planned target volume of prescription n Gy; mPTV50, PTV50 truncated where PTV60 and PTV70 overlap with PTV50; mPTV60, PTV60 truncated where PTV70 overlaps with PTV60.
Figure 1.Axial computed tomography images comparing representative isodoses between two planes. (a) DMPO-RT, (b) fc_DMPO-RT (c) DMPO-RT and (d) fc_DMPO-RT. fc_DMPO-RT was better than DMPO-RT, and the representative feedback competitive belt is marked. GTV, gross tumor volume; DMPO-RT, direct machine parameter optimization radiotherapy method; fc_DMPO-RT, feedback constraint DMPO-RT method; PTV, planned target volume; OAR, organs at risk; CTV, clinical target volume.
Dose distribution parameters and comparisons of PTV70, mPTV60 and mPTV50 for the two plans (n=23 per group).
| Target | Plan | D50%, cGy | D2%, cGy | D98%, cGy | HI | CI |
|---|---|---|---|---|---|---|
| PTV70 | fc_RT | 7340.1±107.0[ | 7903.4±168.8[ | 6767.5±197.1[ | 1.1±0.0 | 0.5±0.1 |
| RT | 7139.0±58.2 | 7695.5±141.5 | 6417.3±298.8 | 1.2±0.0 | 0.4±0.1 | |
| mPTV60 | fc_RT | 6212.6±91.5[ | 7026.3±150.7 | 4767.6±531.8 | 1.3±0.1 | 0.4±0.1 |
| RT | 6127.2±68.1 | 6959.7±92.6 | 4700.8±538.8 | 1.3±0.1 | 0.4±0.1 | |
| mPTV50 | fc_RT | 5102.6±209.5 | 5692.7±88.4 | 3596.2±1272.3 | 1.5±0.4 | 0.5±0.1 |
| RT | 5041.8±172.4 | 5639.9±121.3 | 3540.2±1262.7 | 1.5±0.5 | 0.5±0.1 |
fc_RT, feedback constraint direct machine parameter optimization method; RT, direct machine parameter optimization method; D50%, median dose; D2%, maximum dose; D98%, minimum dose; HI, homogeneity index; CI, conformal index; PTVn, planned target volume of prescription n Gy; mPTV50, PTV50 truncated where PTV60 and PTV70 overlap with PTV50; mPTV60, PTV60 truncated where PTV70 overlaps with PTV60. Values are expressed as the mean ± standard deviation.
t=62.7
t=20.5
t=22.0
t=12.8; P<0.01 vs. RT.
Dose distribution parameters and comparisons of doses to the spinal cord, brainstem, parotid gland, optic chiasm, optic nerve and eye lenses for the 2 plans (n=23 per group).
| A, Spinal cord, brainstem and parotid gland | ||||||
|---|---|---|---|---|---|---|
| Spinal cord | Brainstem | Parotid gland D50%, cGy | ||||
| Plan | D1cm3, cGy | Dmean, cGy | D1cm3, cGy | Dmean, cGy | Left | Right |
| fc_RT | 3907.7±91.3[ | 3178.8±235.0 | 4790.4±238.7 | 3475.2±345.0 | 2304.8±913.1 | 2006.5±436.4 |
| RT | 3982.6±97.1 | 3241.7±217.2 | 4698.8±278.1 | 3463.5±243.5 | 2248.4±928.7 | 1890.7±440.8 |
| B, Optic chiasm, optic nerve and eye lenses | ||||||
| Optic chiasm | Optic nerve | Eye lenses | ||||
| Plan | D1%, cGy | Dmean, cGy | D1%, cGy | Dmean, cGy | D1%, cGy | Dmean, cGy |
| fc_RT | 4993.5±1189.8 | 4168.0±1357.6 | 4662.7±1511.6 | 3061.6±1266.6 | 489.5±46.7 | 401.6±50.5 |
| RT | 4946.0±1128.1 | 4112.4±1384.2 | 4453.8±1421.9 | 3052.5±1329.5 | 498.0±59.0 | 409.5±57.4 |
fc_RT, feedback constraint direct machine parameter optimization method; RT, direct machine parameter optimization method; D1%and D1cm3, maximum dose; Dmean, average dose; D50%, median dose; NPC, nasopharyngeal carcinoma. Values are expressed as the mean ± standard deviation.
t=7.3; P<0.05 vs. RT.
Figure 2.Representative dose-volume histogram from the 2 types of plan, with 33 fractions based on 2 methods. m planned target volume 50 was a virtual prescription of 59.4 Gy for 33 fractions, while the actual irradiated dose was 50.4 Gy for 28 fractions. Left parotid, left parotid gland; right parotid, right parotid gland. DMPO-RT, direct machine parameter optimization radiotherapy method; fc_DMPO-RT, feedback constraint DMPO-RT method; GTV, gross target volume.
Comparison of MUs, segment numbers, delivery time and pass ratio of the 2 plans (n=23).
| Plan | MUs, Mu | Segment numbers | Delivery time, sec | Pass ratio, % |
|---|---|---|---|---|
| fc_RT | 992.4±99.1[ | 39.9±1.7[ | 725.6±36.6[ | 94.8±0.7 |
| RT | 1054.3±67.0 | 67.3±6.4 | 990.6±72.7 | 94.8±0.8 |
fc_RT, feedback constraint direct machine parameter optimization method; RT, direct machine parameter optimization method; MUs, monitor units. Values are expressed as the mean ± standard deviation.
t=6.2
t=393.4
t=244.3; P<0.01 vs. RT.
Comparison of data and MUs resulting from various plans.
| Study | MUs | TPS | Beams | Cancer site |
|---|---|---|---|---|
| Present study | 992.4±99.0 | Pinnacle, V7.6 | 7, UES | Nasopharyngeal |
| Ludlum and Xia, 2008 | 1050 | Pinnacle, V7.6 | 7, UES | Nasopharyngeal |
| Dobler | 944±160 | Oncentra masterplan, V1.5 | 9, ES | Oropharyngeal |
| Oliver | 711.6±68.1 | Pinnacle, V9.0 | 7, ES | Larynx; tonsil; base of tongue; oropharynx; hypopharynx |
MUs, monitor units; TPS, treatment planning system; UES, unequal space; ES, equal space. Values are expressed as the mean ± standard deviation.